Jeffrey Clarine
About Jeffrey Clarine
Jeffrey Clarine is an Associate Director at Mirati Therapeutics, where he has worked since 2021. He has extensive experience in the biotechnology field, having held various scientific positions at companies such as Amgen and Gossamer Bio.
Current Role at Mirati Therapeutics
Jeffrey Clarine serves as Associate Director at Mirati Therapeutics, a position he has held since 2021. His work is based in San Diego, California. In this role, he contributes to the company's research and development efforts, focusing on innovative therapies for cancer treatment.
Previous Experience at Gossamer Bio
Prior to his current role, Clarine worked at Gossamer Bio as a Senior Scientist for five months in 2020. He also held the position of Scientist II at Gossamer Bio from 2019 to 2020 for ten months. His experience at Gossamer Bio involved significant contributions to the company's research initiatives in the biotechnology sector.
Career at Amgen
Jeffrey Clarine has extensive experience at Amgen, where he worked in various roles over a span of several years. He started as an Associate from 2001 to 2004, then progressed to Senior Associate Scientist from 2010 to 2014, and later served as Senior Associate from 2004 to 2007 and Associate Research Scientist from 2007 to 2010. His tenure at Amgen provided him with a solid foundation in biopharmaceutical research.
Education and Expertise
Clarine holds a Master's Degree in Computer Science from California Lutheran University, which he obtained from 2011 to 2014. He also earned a Bachelor's Degree in Chemistry from Gustavus Adolphus College, studying there from 1997 to 2001. His educational background supports his expertise in both scientific research and computational analysis in the biotechnology field.
Experience at eFFECTOR Therapeutics, Inc.
Jeffrey Clarine worked at eFFECTOR Therapeutics, Inc. in two capacities. He served as Research Scientist I from 2014 to 2016 and later as Research Scientist II from 2016 to 2019. His roles at eFFECTOR involved research focused on therapeutic solutions, contributing to the company's mission in the biotechnology landscape.